Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth hormone and bone diseases

H Tanaka1

  • 1Department of Pediatrics, Okayama University Medical School, Japan.

Endocrine Journal
|October 28, 1998
PubMed
Summary

Recombinant human growth hormone (GH) treatment impacts bone density and mineral metabolism. Further research is needed to accurately assess GH

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.

Biochemical and biophysical research communications·1992
Same author

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992
Same author

Substance P induces intracellular calcium increase and translocation of protein kinase C in epidermis.

The British journal of dermatology·1992
Same author

Interleukin-2 production by primary adult T cell leukemia tumor cells is macrophage dependent.

American journal of hematology·1992
Same author

Deletion of mitochondrial DNA in the endomyocardial biopsy sample from a patient with Kearns-Sayre syndrome.

European heart journal·1992
Same author

Entrainment to external Ca2+ oscillation in ionophore-treated Physarum plasmodium.

Cell structure and function·1992

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pediatric Endocrinology

Background:

  • Recombinant human growth hormone (GH) is utilized for treating short stature beyond growth hormone deficiency.
  • Previous studies suggest GH increases bone mineral density (BMD) in growth hormone deficiency (GHD).
  • Conventional BMD calculation methods may overestimate GH's effect by not accounting for bone size changes.

Purpose of the Study:

  • To investigate the precise effects of GH on bone mineral density and size.
  • To explore GH's influence on mineral metabolism and related hormones.
  • To identify potential new therapeutic strategies for metabolic bone disorders.

Main Methods:

  • Utilizing advanced methods for volumetric bone mineral density assessment.
  • Monitoring serum levels of parathyroid hormone (PTH) and active vitamin D metabolites during GH administration.
  • Analyzing changes in bone size and composition in response to GH treatment.

Main Results:

  • GH administration significantly alters serum levels of key mineral-regulating hormones, including PTH and active vitamin D.
  • A more accurate evaluation of volumetric bone mineral density is required to understand GH's true impact.
  • Observed changes in mineral metabolism suggest potential therapeutic applications.

Conclusions:

  • GH treatment influences mineral metabolism through significant hormonal alterations.
  • Accurate assessment of volumetric bone mineral density is crucial for evaluating GH's efficacy.
  • GH-induced changes in mineral metabolism may offer novel treatment avenues for metabolic bone diseases.

Related Experiment Videos